Status:

TERMINATED

Adiana Post-Approval Clinical Study (APACS)

Lead Sponsor:

Hologic, Inc.

Conditions:

Women Contraception

Eligibility:

FEMALE

18-45 years

Brief Summary

The Adiana Post-Approval Clinical Study (APACS) has been designed to compile information on the efficacy and safety of the Adiana Permanent Contraception System in the post market setting. Specificall...

Detailed Description

Adiana Post-Approval Clinical Study is a prospective, single armed, multi-center, observational study that is designed to provide additional efficacy and safety data regarding the FDA-approved Adiana ...

Eligibility Criteria

Inclusion

  • Subjects who are seeking permanent sterilization
  • Women 18-45 years old
  • Subjects who are at risk of becoming pregnant
  • Subjects willing to use alternative contraception for at least three (3) months following device placement and bilateral tubal occlusion is confirmed by HSG
  • Subjects who are able to provide informed consent

Exclusion

  • Subjects who are uncertain about their desire to end fertility
  • Clinical evidence of an active pelvic infection or history of a recent pelvic infection
  • Has intra-uterine pathology which would prevent access to either tubal ostium or the intramural portion of either fallopian tube (i.e., large submucous fibroids, uterine adhesions, apparent uni or bilateral proximal tubal occlusion, suspected unicornuate uterus, etc.)
  • Is pregnant (as evidenced by pregnancy test result) or suspects pregnancy
  • Is currently less than three (3) months since her last pregnancy
  • Has previously undergone a tubal ligation
  • Is currently taking immunosuppressive medication (e.g., steroids)
  • Has a known allergy to contrast media
  • Has external pacemaker or internal cardioverter defibrillator
  • Subject is unable to follow the protocol and return for follow up visits
  • In the opinion of the investigator, the subject has a medical condition that precludes safe participation in the study

Key Trial Info

Start Date :

August 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2012

Estimated Enrollment :

169 Patients enrolled

Trial Details

Trial ID

NCT01177670

Start Date

August 1 2010

End Date

April 1 2012

Last Update

November 20 2012

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

Sutter Medical Group

Elk Grove, California, United States, 95758

2

WomenCare, P.C.

Arlington Heights, Illinois, United States, 60004

3

University of Missouri Health Care

Columbia, Missouri, United States, 65203

4

Valaoras & Lewis Obstetrics and Gynecology

Winston-Salem, North Carolina, United States, 27103